Enveric Biosciences Inc (ENVB)
0.98
+0.05
(+5.89%)
USD |
NASDAQ |
May 03, 11:59
Enveric Biosciences Cash from Financing (TTM): -1.343M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -1.343M |
September 30, 2023 | -1.157M |
June 30, 2023 | 6.772M |
March 31, 2023 | 8.782M |
December 31, 2022 | 18.18M |
September 30, 2022 | 18.18M |
June 30, 2022 | 10.36M |
March 31, 2022 | 9.416M |
December 31, 2021 | 24.90M |
September 30, 2021 | 28.50M |
June 30, 2021 | 28.73M |
March 31, 2021 | 27.24M |
December 31, 2020 | 5.531M |
September 30, 2020 | 1.798M |
June 30, 2020 | 1.571M |
March 31, 2020 | 3.522M |
December 31, 2019 | 1.798M |
September 30, 2019 | 2.224M |
June 30, 2019 | 7.230M |
March 31, 2019 | 5.732M |
December 31, 2018 | 2.694M |
September 30, 2018 | 7.487M |
June 30, 2018 | 2.383M |
March 31, 2018 | 3.486M |
December 31, 2017 | 6.413M |
Date | Value |
---|---|
September 30, 2017 | 0.6573M |
June 30, 2017 | 5.052M |
March 31, 2017 | 9.893M |
December 31, 2016 | 8.798M |
September 30, 2016 | 9.718M |
June 30, 2016 | 10.58M |
March 31, 2016 | 5.651M |
September 30, 2015 | 5.410M |
June 30, 2015 | 5.160M |
March 31, 2015 | -0.002M |
December 31, 2014 | 0.048M |
September 30, 2014 | 0.048M |
June 30, 2014 | 0.0515M |
March 31, 2014 | 0.0585M |
December 31, 2013 | 0.0205M |
September 30, 2013 | 0.0235M |
June 30, 2013 | 0.025M |
March 31, 2013 | 0.02M |
December 31, 2012 | 0.008M |
September 30, 2012 | 0.0079M |
June 30, 2012 | 0.0229M |
March 31, 2012 | 0.0295M |
December 31, 2011 | 0.0475M |
September 30, 2011 | 0.0446M |
June 30, 2011 | 0.0646M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-1.343M
Minimum
Dec 2023
28.73M
Maximum
Jun 2021
10.64M
Average
7.230M
Median
Jun 2019
Cash from Financing (TTM) Benchmarks
Seelos Therapeutics Inc | 11.38M |
Societal CDMO Inc (DELISTED) | 2.342M |
Cardiff Oncology Inc | 0.00 |
BioVie Inc | 15.36M |
Adial Pharmaceuticals Inc | 4.132M |